DECREASE IN HEMATOCRIT ALTER CORONARY STENT PLACEMENT AND DEXTRAN THERAPY

被引：8

作者：

HAUGHT, WH

SOKOL, M

KERENSKY, RA

MEHTA, JL

机构：

[1] VET AFFAIRS MED CTR,GAINESVILLE,FL 32608

[2] UNIV FLORIDA,COLL MED,J HILLIS MILLER HLTH CTR,GAINESVILLE,FL 32610

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1995年 / 76卷 / 04期

关键词：

D O I：

10.1016/S0002-9149(99)80091-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This study was designed to systematically quantitate and determine the cause of a marked discrepancy that we noted in the postprocedural hematocrit of patients undergoing coronary stent placement, and in others undergoing balloon angioplasty despite similar procedural blood loss. We found that dextran 40, when administered after coronary stent placement, results in a marked decrease in hematocrit within 24 hours, which reverts to baseline at 48 hours, and does not require extensive workup;of the patient.

引用

收藏

页码：314 / 315

页数：2

相关论文

共 7 条

[1] ANGIOGRAPHIC AND CLINICAL OUTCOME OF INTRACORONARY STENTING - IMMEDIATE AND LONG-TERM RESULTS FROM A LARGE SINGLE-CENTER EXPERIENCE [J].

CARROZZA, JP ;

KUNTZ, RE ;

LEVINE, MJ ;

POMERANTZ, RM ;

FISHMAN, RF ;

MANSOUR, M ;

GIBSON, CM ;

SENERCHIA, CC ;

DIVER, DJ ;

SAFIAN, RD ;

BAIM, DS .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (02) :328-337

[2] MULTICENTER INVESTIGATION OF CORONARY STENTING TO TREAT ACUTE OR THREATENED CLOSURE AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - CLINICAL AND ANGIOGRAPHIC OUTCOMES [J].

GEORGE, BS ;

VOORHEES, WD ;

ROUBIN, GS ;

FEARNOT, NE ;

PINKERTON, CA ;

RAIZNER, AE ;

KING, SB ;

HOLMES, DR ;

TOPOL, EJ ;

KEREIAKES, DJ ;

HARTZLER, GO .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (01) :135-143

[3]

HAGENBEEK A, 1976, BLOOD CELLS, V2, P437

[4] ISOVOLEMIC HEMODILUTION WITH DEXTRAN-60 AS TREATMENT OF PANCREATIC ISCHEMIA IN ACUTE-PANCREATITIS - CLINICAL PRACTICABILITY OF AN EXPERIMENTAL CONCEPT [J].

KLAR, E ;

FOITZIK, T ;

BUHR, H ;

MESSMER, K ;

HERFARTH, C .

ANNALS OF SURGERY, 1993, 217 (04) :369-374

[5] CLINICAL PHARMACOKINETIC CONSIDERATIONS IN THE USE OF PLASMA EXPANDERS [J].

KLOTZ, U ;

KROEMER, H .

CLINICAL PHARMACOKINETICS, 1987, 12 (02) :123-135

[6] PREVENTION OF EXPERIMENTAL VENOUS THROMBOSIS IN RABBITS WITH LOW-MOLECULAR-WEIGHT HEPARIN, DEXTRAN AND THEIR COMBINATIONS, ADMINISTERED BEFORE OR DURING INDUCTION OF VENOUS ENDOTHELIAL TRAUMA [J].

MATTHIASSON, SE ;

LINDBLAD, B ;

BERGQVIST, D .

THROMBOSIS RESEARCH, 1994, 74 (06) :655-663

[7]

1988, STROKE, V19, P464